Current Edition

Acceleron Pharma

Merck refiles $11.5B Acceleron deal with the FTC. But extending regulators’ review time only one benefit

Merck & Co.’s $11.5 billion bid for Acceleron Pharma is hitting a delay just as activist investors threaten to derail the deal altogether. Merck has …

Continue Reading →
clinical pharmacology research center

SGS Opens New State-of-the-Art Site for Clinical Research in Antwerp, Belgium

SGS officially opens its new clinical pharmacology research center on the Antwerp University Hospital site on October 26, 2021, in the presence of Frankie Ng, SGS CEO, …

Continue Reading →
Clinical Quality Management System

Clinical Quality Management System (CQMS): A Framework for Operational Excellence and Compliance with Good Clinical Practice (GCP)

What defines “quality” within the framework of clinical research? To answer this question, one has to step back and start with the definition of “quality” …

Continue Reading →
clinical research

Emmes Standardises on Veeva Development Cloud to Streamline Product Development

Global CRO builds technology foundation to drive scalability, efficiency, and compliance PLEASANTON, CA — Sept. 16, 2021 — Veeva Systems (NYSE: VEEV) today announced that Emmes is standardizing …

Continue Reading →
clinical research

The End of Data Chaos: Modernising Data Infrastructure to Revolutionise Clinical Research

Clinical research organisations (CROs) are often buried under massive amounts of data that is difficult to analyse effectively and rapidly. Compounding this problem is that …

Continue Reading →
analytics

AEGLE Platform Demonstrations: Big Data analytics in Healthcare

In February 20th and 22nd and March 15th, Aegle is launching a series of webinars with the objective of demonstrating how the final prototype of the AEGLE …

Continue Reading →
clinical research

Clinerion and iHealth Group partner with Bioserv SMO to accelerate clinical research in Brazil by introducing Clinerion’s PRS to the Hospital São Vicente de Paulo

In concert with its Brazilian partner, the iHealth Group, Clinerion has agreed with Bioserv SMO to add Bioserv’s trial sites to the PRS platform. The …

Continue Reading →
biopharmaceutical

TiGenix to present positive 52-week Phase III Cx601 data at EHA-SWG Scientific Meeting

TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells to develop …

Continue Reading →